In D-galactose-induced aging mice, oral administration of the product significantly increased NAD+ levels in liver and adipose tissue, activated mitochondrial energy metabolism pathways, improved insulin sensitivity, lowered blood glucose and lipid levels, reduced visceral fat accumulation, and increased energy expenditure, alleviating fatigue and abnormal body weight associated with aging
Short-term fluctuations between 59F and 86F (15C to 30C) are typically acceptable
A licensed medicinal product and also a non-medicinal product
This is why ex vivo findings need to be confirmed in human trials which subsequent studies like the 2016 GHK peptide clinical trial and the 2021 copper tripeptide serum trial have done
FAQs B12 What is it good for
Injections bypass the gut, and for these patients treatment is often a long-term maintenance strategy guided by their provider